BVXV logo

BiondVax Pharmaceuticals (BVXV) Debt To Equity Ratio

Annual Debt To Equity

-12.24
-41.76-141.46%

December 31, 2022


Summary


Performance

BVXV Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBVXVfinancial healthmetrics:

Quarterly Debt To Equity

-3.46
+1.38+28.51%

June 30, 2023


Summary


Performance

BVXV Quarterly Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBVXVfinancial healthmetrics:

Debt To Equity Formula

Debt To Equity =  
Total Debt
Shareholders Equity

BVXV Debt To Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-141.5%-120.1%
3 y3 years-505.9%-65.5%
5 y5 years-100.0%-379.0%

BVXV Debt To Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-141.5%at low-111.7%+253.8%
5 y5-year-141.5%at low-111.7%+938.7%
alltimeall time-141.5%at low-111.7%+938.7%

BiondVax Pharmaceuticals Debt To Equity History

DateAnnualQuarterly
Jun 2023
-
-3.46(-28.5%)
Mar 2023
-
-4.84(-60.5%)
Dec 2022
-12.24(-141.5%)
-12.24(-284.6%)
Sep 2022
-
6.63(-61.6%)
Jun 2022
-
17.25(+289.4%)
Mar 2022
-
4.43(-85.0%)
Dec 2021
29.52(-741.7%)
29.52(+73.6%)
Sep 2021
-
17.00(+172.4%)
Jun 2021
-
6.24(+88.0%)
Mar 2021
-
3.32(-172.2%)
Dec 2020
-4.60(+127.7%)
-4.60(-87.2%)
Sep 2020
-
-35.94(+1619.6%)
Jun 2020
-
-2.09(+1641.7%)
Mar 2020
-
-0.12(-94.1%)
Dec 2019
-2.02(-33.1%)
-2.02(-64.4%)
Sep 2019
-
-5.67(+245.7%)
Jun 2019
-
-1.64(-48.1%)
Mar 2019
-
-3.16(+4.6%)
Dec 2018
-3.02
-3.02(-202.4%)
DateAnnualQuarterly
Sep 2018
-
2.95(+137.9%)
Jun 2018
-
1.24(>+9900.0%)
Mar 2018
-
0.00(0.0%)
Dec 2017
0.00(0.0%)
0.00(0.0%)
Sep 2017
-
0.00(0.0%)
Jun 2017
-
0.00(0.0%)
Mar 2017
-
0.00(0.0%)
Dec 2016
0.00(0.0%)
0.00(0.0%)
Sep 2016
-
0.00(0.0%)
Jun 2016
-
0.00(0.0%)
Mar 2016
-
0.00(0.0%)
Dec 2015
0.00(0.0%)
0.00(0.0%)
Sep 2015
-
0.00(0.0%)
Jun 2015
-
0.00(0.0%)
Mar 2015
-
0.00(0.0%)
Dec 2014
0.00(0.0%)
0.00(0.0%)
Sep 2014
-
0.00(0.0%)
Dec 2013
0.00(0.0%)
0.00
Dec 2012
0.00
-

FAQ

  • What is BiondVax Pharmaceuticals annual debt to equity ratio?
  • What is the all time high annual debt to equity for BiondVax Pharmaceuticals?
  • What is BiondVax Pharmaceuticals annual debt to equity year-on-year change?
  • What is BiondVax Pharmaceuticals quarterly debt to equity ratio?
  • What is the all time high quarterly debt to equity for BiondVax Pharmaceuticals?
  • What is BiondVax Pharmaceuticals quarterly debt to equity year-on-year change?

What is BiondVax Pharmaceuticals annual debt to equity ratio?

The current annual debt to equity of BVXV is -12.24

What is the all time high annual debt to equity for BiondVax Pharmaceuticals?

BiondVax Pharmaceuticals all-time high annual debt to equity ratio is 29.52

What is BiondVax Pharmaceuticals annual debt to equity year-on-year change?

Over the past year, BVXV annual debt to equity ratio has changed by -41.76 (-141.46%)

What is BiondVax Pharmaceuticals quarterly debt to equity ratio?

The current quarterly debt to equity of BVXV is -3.46

What is the all time high quarterly debt to equity for BiondVax Pharmaceuticals?

BiondVax Pharmaceuticals all-time high quarterly debt to equity ratio is 29.52

What is BiondVax Pharmaceuticals quarterly debt to equity year-on-year change?

Over the past year, BVXV quarterly debt to equity ratio has changed by -20.71 (-120.06%)